Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:1274-1278

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulatero, P.
Right arrow Articles by Veglio, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulatero, P.
Right arrow Articles by Veglio, F.

(Hypertension. 1997;30:1274-1278.)
© 1997 American Heart Association, Inc.


Articles

Impaired Cortisol Binding to Glucocorticoid Receptors in Hypertensive Patients

Paolo Mulatero; Maurizio Panarelli; Domenica Schiavone; Alessandro Rossi; Giulio Mengozzi; Christopher J. Kenyon; Livio Chiandussi; Franco Veglio

From the Department of Medicine and Experimental Oncology, University of Turin, Italy (P.M., D.S., A.R., G.M., L.C., F.V.), and the Departments of Clinical Biochemistry (M.P.) and Medicine (C.J.K.), University of Edinburgh, UK.

Correspondence to Paolo Mulatero, MD, Cattedra Medicina Interna, Ospedale San Vito, Strada San Vito 34, 10133 Torino, Italy.

Abstract We compared glucocorticoid receptor binding characteristics and glucocorticoid responsiveness of human mononuclear leukocytes (HML) from hypertensive patients and matched normotensive volunteers. We also considered associations of these variables with plasma renin activity, aldosterone, cortisol, corticotropin, and electrolyte concentrations. We calculated binding affinity (Kd; nmol/L) and capacity (Bmax; sites/cell) for dexamethasone and cortisol from homologous and heterologous competition curves for specific [3H]dexamethasone binding sites on HML isolated from the blood of normotensive volunteers and subjects with essential hypertension. Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release. We measured plasma hormones by radioimmunoassay. Kd values (mean±SE) for cortisol in HML of hypertensive patients were higher than in control subjects (24.6±2.4 versus 17.5±1.7 nmol/L, P<.04). Binding capacity (4978±391 versus 4131±321 sites/cell), Kd values for dexamethasone (6.7±0.5 versus 5.7±0.3 nmol/L), and IC50 values for dexamethasone (3.4±0.3 versus 3.1±0.2 nmol/L) and cortisol (12.2±1.6 versus 9.5±0.3 nmol/L) were not significantly different. Patients with renin values less than 0.13 ng angiotensin I/L per second were markedly less sensitive to cortisol than those with higher values. Both Kd (30.3±2.5 versus 19.2±2.4 nmol/L) and IC50 values (15.5±1.8 versus 8.9±1.2 nmol/L) for cortisol were significantly higher in patients with lower renin values (P<.03). Other variables, including plasma hormone and electrolyte values and binding characteristics for dexamethasone, were not different. These data suggest that cortisol binding to glucocorticoid receptor is slightly impaired in patients with essential hypertension. In vivo, this could lead to inappropriate binding of cortisol to mineralocorticoid receptors. Hence, decreased sensitivity to cortisol is associated with renin suppression. This hypothesis is supported by evidence of hypertension and low renin activity, which others have described in patients with primary glucocorticoid resistance due to mutations of the glucocorticoid receptor.


Key Words: glucocorticoid receptors • hypertension • cortisol




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. Chamarthi, N. S. Kolatkar, S. C. Hunt, J. S. Williams, E. W. Seely, N. J. Brown, L. J. Murphey, X. Jeunemaitre, and G. H. Williams
Urinary Free Cortisol: An Intermediate Phenotype and a Potential Genetic Marker for a Salt-Resistant Subset of Essential Hypertension
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1340 - 1346.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
W Shamim, M Yousufuddin, D P Francis, P Gualdiero, J W Honour, S D Anker, and A J S Coats
Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance
Heart, August 1, 2001; 86(2): 139 - 144.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. A. Whitworth, G. J. Mangos, and J. J. Kelly
Cushing, Cortisol, and Cardiovascular Disease
Hypertension, November 1, 2000; 36(5): 912 - 916.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. C. Y. Lin, W. Y. S. Wang, and B. J. Morris
Association and Linkage Analyses of Glucocorticoid Receptor Gene Markers in Essential Hypertension
Hypertension, December 1, 1999; 34(6): 1186 - 1192.
[Abstract] [Full Text] [PDF]